Literature DB >> 9266944

Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate.

P Porcu1, C F Danielson, A Orazi, N A Heerema, T G Gabig, L J McCarthy.   

Abstract

The clinical and laboratory data of 48 leukapheresis-treated patients with hyperleucocytic leukaemia (HL) was reviewed to assess the correlation between the degree of leucoreduction and early mortality. Leukapheresis resulted in > 50% leucoreductions and postapheresis WBC counts < 100 x 10(9)/l in most patients (64.5%). Patients presenting with neurological, respiratory or renal complications had higher early mortality rates than patients without such complications, despite similar initial WBC counts and comparable leucoreductions. Thus, in these patients, more efficient leucoreduction was not associated with improved early survival.

Entities:  

Mesh:

Year:  1997        PMID: 9266944     DOI: 10.1046/j.1365-2141.1997.1943011.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Clinical reasoning: a 69-year-old man with leukocytosis and hemorrhagic brain lesions.

Authors:  Kristin M Scott; Faithlore P Gardner; Benjamin H Eidelman; Candido E Rivera; David M Menke; Kevin M Barrett
Journal:  Neurology       Date:  2014-07-01       Impact factor: 9.910

Review 2.  Neurological Complications of the Leukemias Across the Ages.

Authors:  Stephanie Berg; Sucha Nand
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

3.  Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil.

Authors:  L C O Oliveira; L G M Romano; B P A Prado-Junior; D T Covas; E M Rego; G C De Santis
Journal:  Med Oncol       Date:  2009-11-25       Impact factor: 3.064

4.  Therapeutic leukapheresis: 9-year experience in a University Hospital.

Authors:  Ingrid M Parra Salinas; Victoria P González Rodriguez; José A García-Erce
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

5.  Leukocyte Depletion by Therapeutic Leukocytapheresis in Patients with Leukemia.

Authors:  Kristina Hölig; Rainer Moog
Journal:  Transfus Med Hemother       Date:  2012-07-26       Impact factor: 3.747

6.  Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation.

Authors:  Seom Gim Kong; Jung Ho Seo; So Eun Jun; Byung Ki Lee; Young Tak Lim
Journal:  Blood Res       Date:  2014-03-24

7.  [Leukostasis and tumor lysis: important complications of hyperleukocytosis].

Authors:  P Schellongowski; T Staudinger
Journal:  Internist (Berl)       Date:  2013-09       Impact factor: 0.743

Review 8.  Management of Hyperleukocytosis.

Authors:  Antonio Ruggiero; Daniela Rizzo; Maria Amato; Riccardo Riccardi
Journal:  Curr Treat Options Oncol       Date:  2016-02

9.  Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.

Authors:  Rory M Shallis; Maximilian Stahl; Wei Wei; Pau Montesinos; Etienne Lengline; Judith Neukirchen; Vijaya R Bhatt; Mikkael A Sekeres; Amir T Fathi; Heiko Konig; Selina Luger; Irum Khan; Gail J Roboz; Thomas Cluzeau; David Martínez-Cuadron; Emmanuel Raffoux; Ulrich Germing; Jayadev Manikkam Umakanthan; Sudipto Mukhereje; Andrew M Brunner; Adam Miller; Christine M McMahon; Ellen K Ritchie; Rebeca Rodríguez-Veiga; Raphaël Itzykson; Blanca Boluda; Florence Rabian; Mar Tormo; Evelyn Acuña-Cruz; Emma Rabinovich; Brendan Yoo; Isabel Cano; Nikolai A Podoltsev; Jan Philipp Bewersdorf; Steven Gore; Amer M Zeidan
Journal:  Leuk Lymphoma       Date:  2020-02-26

10.  The role of therapeutic leukapheresis in hyperleukocytotic AML.

Authors:  Friederike Pastore; Alessandro Pastore; Georg Wittmann; Wolfgang Hiddemann; Karsten Spiekermann
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.